[Creutzfeldt-Jakob disease]. [Nihon Rinsho. 2004] - PubMed

loading

Old drugs to treat new variant Creutzfeldt-Jakob disease. [Lancet. 2001]
Old drugs to treat new variant Creutzfeldt-Jakob disease.
Love R. Lancet. 2001 Aug 18; 358(9281):563.
Review [Variant Creutzfeldt-Jakob disease]. [Nihon Rinsho. 2004]
Review [Variant Creutzfeldt-Jakob disease].
Ohkubo T, Mizusawa H, Kaneko K. Nihon Rinsho. 2004 Jan; 62 Suppl:252-6.
Drugs for malaria and psychosis may offer hope to people with CJD. [BMJ. 2001]
Drugs for malaria and psychosis may offer hope to people with CJD.
Josefson D. BMJ. 2001 Aug 25; 323(7310):416.
Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects. [Neurology. 2005]
Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects.
Benito-León J. Neurology. 2005 May 24; 64(10):1824; author reply 1824.
Review [Prospects of the therapeutic approaches to Creutzfeldt-Jakob disease: a clinical trial of antimalarial, quinacrine]. [Nihon Rinsho. 2002]
Review [Prospects of the therapeutic approaches to Creutzfeldt-Jakob disease: a clinical trial of antimalarial, quinacrine].
Furukawa H, Takahashi M, Nakajima M, Yamada T. Nihon Rinsho. 2002 Aug; 60(8):1649-57.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

[Creutzfeldt-Jakob disease].
[Creutzfeldt-Jakob disease].
Nihon Rinsho. 2004 Jan ;62 Suppl:244-7.

PubMed
Biochemical and pharmacological properties of SR 46349B, a new potent and select...
Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
J Pharmacol Exp Ther. 1992 Aug ;262(2):759-68.

PubMed
Alternative graft materials for hemodialysis access.
Alternative graft materials for hemodialysis access.
Semin Vasc Surg. 2004 Mar ;17(1):19-24.

PubMed
Preferred amino acids and thermostability.
Preferred amino acids and thermostability.
Genet Mol Res. 2003 Dec 30 ;2(4):383-93.

PubMed
Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metasta...
Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer.
Oncol Rep. 2004 Apr ;11(4):753-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed